References
- 1
Schultz C.
Link A.
Leost M.
Zaharevitz DW.
Gussio R.
Sausville EA.
Meijer L.
Kunick C.
J. Med. Chem.
1999,
42:
2909
-
2a
Blaser HU.
Boyer S.
Pittelkow U.
Tetrahedron: Asymmetry
1991,
2:
721
-
2b
Boyer SK.
Pfund RA.
Portmann RE.
Sedelmeier GH.
Wetter HF.
Helv. Chim. Acta
1988,
71:
337
-
2c
Watthey JWH.
Stanton JL.
Desai M.
Babiarz JE.
Finn BM.
J. Med.Chem.
1985,
28:
1511
- 3
Hansen TH.
Thøgersen H.
Hansen BS.
Bioorg. Med. Chem. Lett.
1997,
7:
2951
-
4a
Das J.
Floyd DM.
Kimball DS.
Duff KJ.
Truc ChiVu.
Lago MW.
Moquin RV.
Lee VG.
Gougoutas JZ.
Malley MF.
Moreland S.
Brittain RJ.
Hedberg SA.
Cucinotta GG.
J.
Med. Chem.
1992,
35:
773
-
4b
Das J.
Floyd DM.
Kimball DS.
Duff KJ.
Lago MW.
Krapcho J.
White R.
Ridgewell R.
Obermeier MT.
Moreland S.
McMullen D.
Normandin D.
Hedberg SA.
Schaeffer T.
J.
Med. Chem.
1992,
35:
2610
-
5a
Rickards RW.
Smith RM.
Tetrahedron Lett.
1966,
2361
-
5b
Kozikowski AP.
Ma D.
Brewer J.
Sun S.
Costa E.
Romeo E.
Guidotti A.
J. Med.
Chem.
1993,
36:
2908
- 6
Duchardt KH.
Kröhnke F.
Chem. Ber.
1977,
110:
2669
- 7
Maeda M.
Chem.
Pharm. Bull.
1990,
38:
2577
- 8
Grignon-Dubois M.
Diaba F.
Grellier-Marly M.-C.
Synthesis
1994,
800
-
10a
MacPhillamy HB.
Dziemian RL.
Lucas RA.
Kuehne ME.
J. Am. Chem. Soc.
1958,
80:
2172
-
10b
Kunick C.
Arch
Pharm.
1991,
324:
579
-
11a
Hauser FM.
Prasanna S.
Synthesis
1980,
621
-
11b
Baskaran S.
Das J.
Chandrasekaran S.
J.
Org. Chem.
1989,
54:
5182
- 14 For a recent example of a proline
derivative enlargement, see: Cossy J.
Dumas C.
Gomez Pardo D.
Synlett
1997,
905
9
Spectral Data for
Compound 5:
IR (KBr): 1659, 1615, 1595 cm-1. 1H
NMR (200 MHz, CDCl3): δ = 3.40
(s, 3 H, OCH
3), 4.82 (br s,
1 H, CHOCH3), 5.08 and 5.40
(AB system, J = 15.2
Hz, 2 H, NCH
2), 5.84 (d, J = 11.2 Hz,
1 H, COCH=CH), 6.51 (dd, J = 11.2 and
4.0 Hz, 1 H, COCH=CH), 7.05-7.45
(m, 9 H, Ar). 13C NMR (50 MHz, CDCl3): δ = 52.4,
57.7, 77.2, 121.3, 122.6, 123.1, 125.7, 127.3, 127.4, 127.5 (2 C),
128.5 (2 C), 137.7, 138.3 (2 quaternary carbons), 146.1, 166.5.
MS: m/z (relative intensity) = 279(8) [M+],
264(19), 246(30), 91(100), 65(18). HRMS (SIMS) calcd for C18H17NO2 + H:
280.1338; found: 280.1342.
12 For a close example of Beckmann rearrangement,
see ref.
[2b]
13
Spectral Data
for Compounds 9 and 10:
9:
IR (KBr): 1667 cm-1. 1H
NMR (200 MHz, CDCl3): δ = 1.70-1.90
(m, 1 H, CH
2CHOCH3),
2.15-2.35 (m, 2 H, CH
2CO),
2.45-2.65 (m, 1 H, CH
2CHOCH3),
3.06 (s, 3 H, OCH
3), 4.01
(dd, J = 10.4
and 6.8 Hz, 1 H, CHOCH3),
4.63 and 5.37 (AB system, J = 14.4
Hz, 2 H, NCH
2), 7.10-7.35 (m,
9 H, Ar). 13C NMR (50 MHz, CDCl3): δ = 31.8,
35.4, 51.3, 57.6, 77.5, 123.3, 124.6, 126.7, 127.5, 128.1, 128.5
(4 C; the ortho and meta carbons of the phenyl ring are identical),
135.9, 137.6, 140.5, 172.6. MS: m/z (relative intensity) = 281(24) [M+],
194(58), 130(100), 91(90), 65(22). HRMS (SIMS) calcd for C18H19NO2 + H:
282.1494; found: 282.1491.
10:
IR (KBr): 1674 cm-1; 1H
NMR (200 MHz, CDCl3): δ = 2.00-2.20
(m, 1 H of the CH2CH2 motif), 2.30-2.60
(m, 3 H of the CH2CH2 motif), 3.32 (s, 3 H,
OCH
3), 3.70-3.85 (m,
1 H, CHOCH3), 4.90 and 5.24
(AB system, J = 14.8
Hz, 2 H, NCH
2), 7.05-7.30
(m, 9 H, Ar). 13C NMR (50 MHz, CDCl3): δ = 27.8,
36.2, 51.8, 57.9, 78.1, 123.1, 126.7, 127.5, 127.8, 128.3 (2 C),
128.5 (2 C), 129.1, 136.1, 137.6, 140.7, 171.6. MS: m/z (relative intensity) = 281(96) [M+],
132(79), 118(76), 91(100), 65(20). HRMS (SIMS) calcd for C18H19NO2 + H:
282.1494; found: 282.1495.